Mendelspod PodcastLong DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech 811×Preview0:00Current time: 0:00 / Total time: -8:12-8:12Audio playback is not supported on your browser. Please upgrade.Long DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech Theral TimpsonSep 13, 2023∙ Paid81ShareChapters:0:00 World’s longest oligo8:45 Why is it difficult to synthesize long DNA?12:00 Proprietary TdT conjugate16:00 A billion-dollar market24:20 The computation model and its challenges28:35 More customers using generative AIMendelspod is now reader supported. Please consider upgrading to a paid subscription for the price of a couple cof…SubscribeContinue reading this post for free, courtesy of Theral Timpson.Claim my free postOr purchase a paid subscription.Mendelspod PodcastOffering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.SubscribeListen onSubstack AppRSS FeedAppears in episodeTheral TimpsonRecent EpisodesBuilding the Diagnostic Layer of Modern Cancer Care with Rita Shaknovich and Karina Kulangara of AgilentMay 29 • Theral TimpsonMapping the Multi-Omic Era with Eric Green of IlluminaMay 28 • Theral TimpsonInside Proteomics at Thermo Fisher with Yan ZhangMay 21 • Theral TimpsonSeparating Epigenetic Signals Improves Early Cancer Detection with Rob Osborne, BiomodalMay 19 • Theral TimpsonDigital Controls for Cancer Drug Trials? Irina Babina, ConcrMay 15 • Theral TimpsonSolexa Co-Inventor Shankar Balasubramanian on Six-Base Sequencing and What's Next in GenomicsMay 7 • Theral TimpsonThe Next Frontier in Biology: Physics? Erdinc Sezgin of the Karolinska InstituteApr 30 • Theral TimpsonThe Case for a 6-Base Genome with Peter Fromen, CEO of BiomodalApr 28 • Theral Timpson